F Honecker
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
Honecker F, Huddart R, Jewett M, Joly F, Lauritsen J, Lorch A, Necchi A, Nicolai N, Oing C, Oldenburg J, Ondruš D, Papachristofilou A, Powles T, Sohaib A, Ståhl O, Tandstad T, Toner G, Hemminki K, Heidenreich A, Aparicio J, Berney D, Beyer J, Bokemeyer C, Cathomas R, Clarke N, Cohn-Cedermark G, Daugaard G, Dieckmann K, Fizazi K, Fosså S, Germà-Lluch J, Giannatempo P, Gietema J, Gillessen Sommer S, Haugnes H, Horwich A. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann Oncol 2018; 29:1658-1686.
01.08.2018ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
01.08.2018Ann Oncol 2018; 29:1658-1686
Honecker F, Huddart R, Jewett M A S, Joly F, Lauritsen J, Lorch A, Necchi A, Nicolai N, Oing C, Oldenburg J, Ondruš D, Papachristofilou A, Powles T, Sohaib A, Ståhl O, Tandstad T, Toner G, Hemminki K, Heidenreich A, Aparicio J, Berney D, Beyer J, Bokemeyer C, Cathomas R, Clarke N, Cohn-Cedermark G, Daugaard G, Dieckmann K-P, Fizazi K, Fosså S, Germà-Lluch J R, Giannatempo P, Gietema J A, Gillessen Sommer Silke, Haugnes H S, Horwich A
Personalizing, not patronizing: The case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
Oldenburg J, Gillessen Sommer S, Haugnes H, Honecker F, Horwich A, Lorch A, Ondruscaron D, Rosti G, Stephenson A, Germà-Lluch J, Fossa S, Aparicio J, Beyer J, Cohn-Cedermark G, Cullen M, Gilligan T, De Giorgi U, De Santis M, De Wit R, Tandstad T. Personalizing, not patronizing: The case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Ann Oncol 2014
06.11.2014Personalizing, not patronizing: The case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
06.11.2014Ann Oncol 2014
Oldenburg J, Gillessen Sommer Silke, Haugnes H S, Honecker F, Horwich A, Lorch A, Ondruscaron D, Rosti G, Stephenson A, Germà-Lluch J R, Fossa S D, Aparicio J, Beyer J, Cohn-Cedermark G, Cullen M, Gilligan T, De Giorgi U, De Santis M, De Wit R, Tandstad T
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
Wittekind C, Nuver J, Nicolai N, Necchi A, Mayer F, Lotz J, Lorch A, Looijenga L, Laguna M, Krege S, Kollmannsberger C, Kliesch S, Huddart R, Oechsle K, Oldenburg J, Oosterhuis J, Winter C, Tandstad T, Souchon R, Sohaib A, Sedlmayer F, Schweyer S, Schrader M, Salvioni R, Rosti G, Rick O, Rajpert-De Meyts E, Powles T, Horwich A, Honecker F, Hentrich M, Daugaard G, Dahl A, Cohn-Cedermark G, Classen J, Clarke N, Cavallin-Stahl E, Cathomas R, Busch J, Bokemeyer C, Aparicio J, Altena R, Albers P, De Giorgi U, De Santis M, De Wit M, Heidenreich A, Hartmann J, Giwercman A, Gillessen S, Gietema J, Germá Lluch J, Fossa S, Fléchon A, Fizazi K, Fenner M, Dieckmann K, De Wit R, Beyer J. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol 2012; 24:878-88.
14.11.2012Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
14.11.2012Ann Oncol 2012; 24:878-88
Wittekind C, Nuver J, Nicolai N, Necchi A, Mayer F, Lotz J P, Lorch A, Looijenga L H J, Laguna M P, Krege S, Kollmannsberger C, Kliesch S, Huddart R A, Oechsle K, Oldenburg J, Oosterhuis J W, Winter C, Tandstad T, Souchon R, Sohaib A, Sedlmayer F, Schweyer S, Schrader M, Salvioni R, Rosti G, Rick O, Rajpert-De Meyts E, Powles T, Horwich A, Honecker F, Hentrich M, Daugaard G, Dahl A A, Cohn-Cedermark G, Classen J, Clarke N W, Cavallin-Stahl E, Cathomas R, Busch J, Bokemeyer C, Aparicio J, Altena R, Albers P, De Giorgi U, De Santis M, De Wit M, Heidenreich A, Hartmann J T, Giwercman A, Gillessen S, Gietema J A, Germá Lluch J R, Fossa S D, Fléchon A, Fizazi K, Fenner M, Dieckmann K P, De Wit R, Beyer J
A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)
Kollmannsberger C, Schittenhelm M, Honecker F, Tillner J, Weber D, Oechsle K, Kanz L, Bokemeyer C. A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC). Ann Oncol 2006; 17:1007-13.
13.03.2006A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)
13.03.2006Ann Oncol 2006; 17:1007-13
Kollmannsberger C, Schittenhelm Marcus, Honecker F, Tillner J, Weber D, Oechsle K, Kanz L, Bokemeyer C
Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro
Koch S, Mayer F, Honecker F, Schittenhelm M, Bokemeyer C. Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro. Br J Cancer 2003; 89:2133-9.
01.12.2003Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro
01.12.2003Br J Cancer 2003; 89:2133-9
Koch S, Mayer F, Honecker F, Schittenhelm Marcus, Bokemeyer C